Asset Details
Do you wish to reserve the book?
Diffusion kurtosis imaging biomarkers associated with amelioration of neuroinflammation, gray matter microstructural abnormalities, and gut dysbiosis by central thalamic deep brain stimulation in autistic -like young rats
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Diffusion kurtosis imaging biomarkers associated with amelioration of neuroinflammation, gray matter microstructural abnormalities, and gut dysbiosis by central thalamic deep brain stimulation in autistic -like young rats
Do you wish to request the book?
Diffusion kurtosis imaging biomarkers associated with amelioration of neuroinflammation, gray matter microstructural abnormalities, and gut dysbiosis by central thalamic deep brain stimulation in autistic -like young rats
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Diffusion kurtosis imaging biomarkers associated with amelioration of neuroinflammation, gray matter microstructural abnormalities, and gut dysbiosis by central thalamic deep brain stimulation in autistic -like young rats
2025
Overview
•CTN-DBS treatment demonstrated thermal safety by meeting SAR-induced RF heating standards, ensuring no adverse heating effects.•Precise activation of CTN was confirmed through VTA analysis, highlighting its targeted therapeutic impact.•CTN-DBS significantly improved grey matter microstructure, with increased MK, AK, and RK, reflecting enhanced neuronal complexity.•Neuroinflammation was attenuated, with reduced astrocyte, microglial activation and decreased systemic pro-inflammatory cytokines, improving gut barrier integrity and mitigating dysbiosis.•DKI was validated as a robust biomarker, linking CTN-DBS-induced microstructural improvements to behavioral and gut health benefits.
Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by abnormalities in brain microstructure, neuroinflammation, and social behavior deficits. In addition, children with ASD frequently exhibit irritable bowel syndrome and other gastrointestinal symptoms linked to anxiety. This study investigated if central thalamic nucleus deep brain stimulation (CTN-DBS) can improve social behavior, suppress neuroinflammation, restore brain microstructure, and reverse gut dysbiosis in the valproic acid-induced rat model of ASD by modulating the microbiota–gut–brain (MGB) axis. Daily CTN-DBS for 7 days (30 min/day) enhanced neuronal density, organization, and microstructural complexity as evidenced by increases in the diffusion kurtosis imaging (DKI) metrics—mean kurtosis (MK), axial kurtosis (AK), and radial kurtosis (RK). These neurostructural improvements were associated with reduced astrocyte and microglial activation, two core hallmarks of neuroinflammation in ASD, and lower systemic levels of the pro-inflammatory cytokines interleukin (IL)-1β, IL-6, interferon (IFN)-γ, and tumor necrosis factor (TNF)-α, signaling factors that may increase gut permeability and disrupt gut microbial composition. Indeed, CTN-DBS enhanced gut barrier function, promoted the proliferation of beneficial Bacteroides spp., and improved short-chain fatty acid (SCFA) metabolism, thereby restoring normal gut acetate and butyrate levels and counteracting dysbiosis. Specific energy absorption rate and thermal effect analyses demonstrated that CTN-DBS is safe under DKI. These findings support CTN-DBS as a safe and efficacious therapeutic strategy to reduce neuroinflammation, restore gray matter circuit function, and improve gut microbial composition in ASD via MGB axis modulation. Furthermore, DKI can reveal neurobiomarkers indicative of these improvements in ASD model rats.
Publisher
Elsevier Inc,Elsevier Limited,Elsevier
Subject
/ Animals
/ Autism
/ Autism Spectrum Disorder - chemically induced
/ Autism Spectrum Disorder - diagnostic imaging
/ Autism Spectrum Disorder - therapy
/ Deep Brain Stimulation - methods
/ Diffusion Tensor Imaging - methods
/ Dysbiosis - diagnostic imaging
/ Gastrointestinal Microbiome - physiology
/ Gray Matter - diagnostic imaging
/ Kurtosis
/ Male
/ Neurodevelopmental disorders
/ Neuroinflammatory Diseases - diagnostic imaging
/ Neuroinflammatory Diseases - therapy
/ Radiology/Diagnostic Imaging
/ Rats
/ Thalamus
